These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. [Neurocysticercosis: up-dating in diagnosis and treatment]. Del Brutto OH Neurologia; 2005 Oct; 20(8):412-8. PubMed ID: 16217690 [TBL] [Abstract][Full Text] [Related]
4. Neurocysticercosis: a review of current status and management. Sinha S; Sharma BS J Clin Neurosci; 2009 Jul; 16(7):867-76. PubMed ID: 19394828 [TBL] [Abstract][Full Text] [Related]
5. [Neurocysticercosis--pathogenesis and clinical aspects]. Nikolić S; Stevanović G Srp Arh Celok Lek; 2006; 134(5-6):246-50. PubMed ID: 16972416 [TBL] [Abstract][Full Text] [Related]
6. CSF-VP shunt placement and albendazole therapy for cerebral cysticercosis. Zhu L; Weng X; Shi Y; Pan X; Mo L Chin Med J (Engl); 2002 Jun; 115(6):936-8. PubMed ID: 12136810 [TBL] [Abstract][Full Text] [Related]
7. [Therapeutic approach to neurocysticercosis]. Canak G; Ilić A Med Pregl; 1998; 51 Suppl 1():57-60. PubMed ID: 9769658 [TBL] [Abstract][Full Text] [Related]
9. [Neurocysticercosis: its aetiopathogenesis, clinical manifestations, diagnosis and treatment]. Alarcón F Rev Neurol; 2006 Oct; 43 Suppl 1():S93-100. PubMed ID: 17061203 [TBL] [Abstract][Full Text] [Related]
10. A rare case of racemose neurocysticercosis and its complications. Case report. Pamplona J; Braz A; Conceição C; Rios C; Reis J Neuroradiol J; 2015 Aug; 28(4):418-20. PubMed ID: 26416817 [TBL] [Abstract][Full Text] [Related]